| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |